Literature DB >> 3260243

Relationship of health-related variables to levels of anti-polyribosylribitol phosphate antibodies in adults.

W M McDonnell1, J R Gilsdorf, J B Kent, J N Sheagren.   

Abstract

To identify adults who may be at risk for Haemophilus influenzae type b disease by virtue of low levels of antibody against the H. influenzae b capsule and who may thus benefit from receiving H. influenzae b vaccine, we correlated serum anticapsular antibody levels of 388 adult patients with 26 health-related variables, including 3 personal characteristics, 10 laboratory values, 4 drug use categories, and 8 disease categories. Steroid use was consistently associated with low levels of anticapsular antibody; associations were also found between low antibody levels and both non-Caucasian race and increasing age. However, less than 4% of the antibody variability could be attributed to these factors, and they were not predictive of low antibody levels. Thus, although H. influenzae b infections are seen in adults with predisposing medical conditions, on the basis of the present findings, use of the H. influenzae b vaccine in adults cannot be recommended.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260243      PMCID: PMC266562          DOI: 10.1128/jcm.26.6.1202-1206.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  The association of bacteremic Haemophilus influenzae pneumonia in adults with typable strains.

Authors:  R Quintiliani; P J Hymans
Journal:  Am J Med       Date:  1971-06       Impact factor: 4.965

2.  Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine.

Authors:  H Peltola; H Käyhty; M Virtanen; P H Mäkelä
Journal:  N Engl J Med       Date:  1984-06-14       Impact factor: 91.245

3.  Immunospecificity and quantitation of an enzyme-linked immunosorbent assay for group B streptococcal antibody.

Authors:  B F Anthony; N F Concepcion; S A McGeary; J I Ward; D C Heiner; P Shapshak; R A Insel
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

4.  The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.

Authors:  H Käyhty; H Peltola; V Karanko; P H Mäkelä
Journal:  J Infect Dis       Date:  1983-06       Impact factor: 5.226

5.  Hemophilus influenzae in hospitalized adults: current perspectives.

Authors:  H B Simon; F S Southwick; R C Moellering; E Sherman
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

6.  Meningitis due to Haemophilus influenzae other than type b: case report and review.

Authors:  G R Greene
Journal:  Pediatrics       Date:  1978-12       Impact factor: 7.124

7.  Haemophilus influenzae infections in adults: characterization of strains by serotypes, biotypes, and beta-lactamase production.

Authors:  R J Wallace; D M Musher; E J Septimus; J E McGowan; F J Quinones; K Wiss; P H Vance; P A Trier
Journal:  J Infect Dis       Date:  1981-08       Impact factor: 5.226

8.  A radioactive antigen-binding assay for the measurement of antibody to Haemophilus influenzae type b capsular polysaccharide.

Authors:  J S Kuo; N Monji; R S Schwalbe; D W McCoy
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

9.  Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.

Authors:  H Peltola; H Käyhty; A Sivonen; H Mäkelä
Journal:  Pediatrics       Date:  1977-11       Impact factor: 7.124

10.  Haemophilus influenzae non-type b infections in children.

Authors:  J R Gilsdorf
Journal:  Am J Dis Child       Date:  1987-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.